Inventor · disambiguated record
Martha E. Rodriguez
Also filed as: RODRIGUEZ MARTHA · RODRIGUEZ MARTHA E
25 granted patents·14 pending applications·803 citations·filing 2001–2025
96Inventor score
Files withARRAY BIOPHARMA INC14MIRATI THERAPEUTICS INC11COGENT BIOSCIENCES INC5BOYS MARK LAURENCE2ANDREWS STEVEN W1
Top patents by PatentIndex Score
39 records- 0197US10689377B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Jun 23, 2020·16 cites·57 claims
- 0296US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0396US10125134B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Nov 13, 2018·43 cites·9 claims
- 0496US7799782B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 21, 2010·600 cites·23 claims
- 0593US10633381B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·8 cites·7 claims
- 0692US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0789US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 0889US7135575B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2003·Granted Nov 14, 2006·29 cites·16 claims
- 0985US7521447B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Apr 21, 2009·28 cites·33 claims
- 1084US6911443B2Imidazopyrimidine derivatives and triazolopyrimidine derivativesBAYER AG·Filed 2001·Granted Jun 28, 2005·32 cites·7 claims
- 1183US8044083B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 1282US2024101553A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1379US8039639B2Kinase inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Granted Oct 18, 2011·4 cites·1 claims
- 1479US2024124453A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1578US6586467B2Preparation of phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2001·Granted Jul 1, 2003·11 cites·16 claims
- 1678US2023373999A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1777US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1876US2025066357A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1975US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 2074US11884664B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2022·Granted Jan 30, 2024·0 cites·16 claims
- 2173US8017641B2P38 inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2009·Granted Sep 13, 2011·1 cites·10 claims
- 2272US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 2371US8518983B2P38 inhibitors and methods of use thereofMUNSON MARK·Filed 2009·Granted Aug 27, 2013·2 cites·8 claims
- 2468US12351581B2Compounds for FGFR inhibitionCOGENT BIOSCIENCES INC·Filed 2024·Granted Jul 8, 2025·0 cites·30 claims
- 2567US12281122B1PI3K inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 2667US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 2766US8809538B2Piperidine-containing compounds and use thereofRODRIGUEZ MARTHA E·Filed 2010·Granted Aug 19, 2014·2 cites·6 claims
- 2863US12187721B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
- 2962US8841455B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitorsBOYS MARK LAURENCE·Filed 2010·Granted Sep 23, 2014·1 cites·41 claims
- 3058US2025270211A1Compounds for fgfr inhibitionCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3157US2024034733A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3256US2024270741A1Compounds for fgfrs inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3355US2023357277A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3455US2004180896A1P38 inhibitors and methods of use thereofFiled 2003·Application pending·0 cites
- 3553US2023279025A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3652US2008269265A1Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl UreasMILLER SCOTT·Filed 2008·Application pending·0 cites
- 3748US2025206752A1Pi3k inhibitorsCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3837US2003229072A1Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agentsFiled 2001·Application pending·0 cites
- 3936US8865726B2Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsANDREWS STEVEN W·Filed 2010·Granted Oct 21, 2014·0 cites·45 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →